Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  Meganathan, K ^a,d   Jagtap, S ^a,e   Srinivasan, S P ^a   Wagh, V ^a,e   Hescheler, J ^a   Hengstler, J ^b   Leist, M ^c   Sachinidis, A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; BETA TUBULIN; DNA METHYLTRANSFERASE 3A; MESSENGER RNA; MICRORNA; MICRORNA 378; MICROTUBULE ASSOCIATED PROTEIN 2; OSTEOGENIC PROTEIN 1; SEMAPHORIN 3A; TRANSCRIPTION FACTOR EMX2; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR HES 5; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SOX10; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT; HISTONE DEACETYLASE INHIBITOR;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEVELOPMENTAL GENE; DEVELOPMENTAL TOXICITY; EMBRYO; FOREBRAIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IN VIVO STUDY; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NEURAL TUBE; PRIORITY JOURNAL; TRANSCRIPTOMICS; UPREGULATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY; PROCEDURES; TOXICITY TESTING;

CELL DIFFERENTIATION; GENOME-WIDE ASSOCIATION STUDY; HISTONE DEACETYLASE INHIBITORS; HUMAN EMBRYONIC STEM CELLS; HUMANS; MICRORNAS; NEUROGENESIS; NEURONS; TOXICITY TESTS;

EID: 84934348862     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.121     Document Type: Article

References (75)

1. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol 2014;13:330-338.
2. Krug AK, Kolde R, Gaspar JA, Rempel E, Balmer NV, Meganathan K et al. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 2013;87:123-143.
3. Meganathan K, Jagtap S, Wagh V, Winkler J, Gaspar JA, Hildebrand D et al. Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS One 2012;7:e44228.
4. Leist M, Hartung T, Nicotera P. The dawning of a new age of toxicology. ALTEX 2008;25:103-114.
5. Leist M, Bremer S, Brundin P, Hescheler J, Kirkeby A, Krause KH et al. The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 2008;25:163-190.
6. Andersen ME, Krewski D. Toxicity testing in the 21st century: bringing the vision to life. Toxicol Sci 2009;107:324-330.
7. Gaspar JA, Doss MX, Winkler J, Wagh V, Hescheler J, Kolde R et al. Gene expression signatures defining fundamental biological processes in pluripotent, early, and late differentiated embryonic stem cells. Stem Cells Dev 2012;21:2471-2484.
8. Schulz H, Kolde R, Adler P, Aksoy I, Anastassiadis K, Bader M et al. The FunGenES database: a genomics resource for mouse embryonic stem cell differentiation. PLoS One 2009;4:e6804.
9. Cho A, Ko HW, Eggenschwiler JT. FKBP8 cell-autonomously controls neural tube patterning through a Gli2- and Kif3a-dependent mechanism. Dev Biol 2008;321:27-39.
10. Jagtap S, Meganathan K, Gaspar J, Wagh V, Winkler J, Hescheler J et al. Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol 2011;162:1743-1756.
11. Cezar GG. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs? Curr Opin Chem Biol 2007;11:405-409.
12. Pouton CW, Haynes JM. Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov 2007;6:605-616.
13. Vorhees CV. Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 1987;35:195-202.
14. Braam SR, Tertoolen L, van de SA, Meyer T, Passier R, Mummery CL. Prediction of druginduced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010;4:107-116.
15. Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J et al. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci 2011;124:370-377.
16. He X, Imanishi S, Sone H, Nagano R, Qin XY, Yoshinaga J et al. Effects of methylmercury exposure on neuronal differentiation of mouse and human embryonic stem cells. Toxicol Lett 2012;212:1-10.
17. Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J et al. Characterisation of a neural teratogenicity assay based on human ESCs differentiation following exposure to valproic acid. Curr Med Chem 2012;19:6065-6071.
18. Cotariu D, Zaidman JL. Developmental toxicity of valproic acid. Life Sci 1991;48:1341-1350.
19. Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007;5:981-989.
20. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 2006;12:1147-1150.
21. Duncan S. Teratogenesis of sodium valproate. Curr Opin Neurol 2007;20:175-180.
22. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 2009;28:1-10.
23. Nau H, Hauck RS, Ehlers K. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol Toxicol 1991;69:310-321.
24. Jergil M, Kultima K, Gustafson AL, Dencker L, Stigson M. Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. Toxicol Sci 2009;108:132-148.
25. Menegola E, Di RF, Broccia ML, Giavini E. Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res C Embryo Today 2006;78:345-353.
26. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403:901-906.
27. Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007;32:189-197.
28. Fineberg SK, Kosik KS, Davidson BL. MicroRNAs potentiate neural development. Neuron 2009;64:303-309.
29. Gao FB. Posttranscriptional control of neuronal development by microRNA networks. Trends Neurosci 2008;31:20-26.
30. Lema C, Cunningham MJ. MicroRNAs and their implications in toxicological research. Toxicol Lett 2010;198:100-105.
31. Hudder A, Novak RF. miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci 2008;103:228-240.
32. Reamon-Buettner SM, Borlak J. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation. Reprod Toxicol 2007;24:20-30.
33. Bruckner A, Lee YJ, O'Shea KS, Henneberry RC. Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture. Teratology 1983;27:29-42.
34. Castilla E. Valproic acid and spina bifida. Lancet 1983;2:683.
35. Ehlers K, Sturje H, Merker HJ, Nau H. Valproic acid-induced spina bifida: a mouse model. Teratology 1992;45:145-154.
36. Oakeshott P, Hunt GM. Valproate and spina bifida. BMJ 1989;298:1300-1301.
37. Turner S, Sucheston ME, De Philip RM, Paulson RB. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate. Teratology 1990;41:421-442.
38. Zhao Y, Xiong Q, Xie P. Analysis of microRNA expression in embryonic developmental toxicity induced by MC-RR. PLoS One 2011;6:e22676.
39. Balmer NV, Weng MK, Zimmer B, Ivanova VN, Chambers SM, Nikolaeva E et al. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet 2012;21:4104-4114.
40. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001;20:6969-6978.
41. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001;276:36734-36741.
42. Ruau D, Ensenat-Waser R, Dinger TC, Vallabhapurapu DS, Rolletschek A, Hacker C et al. Pluripotency associated genes are reactivated by chromatin-modifying agents in neurosphere cells. Stem Cells 2008;26:920-926.
43. Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 2009;4:359-369.
44. Karantzali E, Schulz H, Hummel O, Hubner N, Hatzopoulos A, Kretsovali A. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. Genome Biol 2008;9:R65.
45. Biermann J, Boyle J, Pielen A, Lagreze WA. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. Mol Vis 2011;17:395-403.
46. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-797.
47. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH. Histone deacetylase inhibitionmediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 2004;101:16659-16664.
48. Feng J, Fouse S, Fan G. Epigenetic regulation of neural gene expression and neuronal function. Pediatr Res 2007;61:58R-63R.
49. Macdonald JL, Roskams AJ. Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation. Prog Neurobiol 2009;88:170-183.
50. Copp AJ, Greene ND. Genetics and development of neural tube defects. J Pathol 2010;220:217-230.
51. Acampora D, Mazan S, Lallemand Y, Avantaggiato V, Maury M, Simeone A et al. Forebrain and midbrain regions are deleted in Otx2-/-mutants due to a defective anterior neuroectoderm specification during gastrulation. Development 1995;121:3279-3290.
52. Kimura C, Yoshinaga K, Tian E, Suzuki M, Aizawa S, Matsuo I. Visceral endoderm mediates forebrain development by suppressing posteriorizing signals. Dev Biol 2000;225:304-321.
53. Matsuo I, Kuratani S, Kimura C, Takeda N, Aizawa S. Mouse Otx2 functions in the formation and patterning of rostral head. Genes Dev 1995;9:2646-2658.
54. Yoshida M, Suda Y, Matsuo I, Miyamoto N, Takeda N, Kuratani S et al. Emx1 and Emx2 functions in development of dorsal telencephalon. Development 1997;124:101-111.
55. Hu N, Strobl-Mazzulla PH, Bronner ME. Epigenetic regulation in neural crest development. Dev Biol 2014;396:159-168.
56. Khudyakov J, Bronner-Fraser M. Comprehensive spatiotemporal analysis of early chick neural crest network genes. Dev Dyn 2009;238:716-723.
57. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 1998;18:237-250.
58. Nakagawa S, Takeichi M. Neural crest emigration from the neural tube depends on regulated cadherin expression. Development 1998;125:2963-2971.
59. Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 1998;18:60-64.
60. Murko C, Lagger S, Steiner M, Seiser C, Schoefer C, Pusch O. Histone deacetylase inhibitor trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube. Differentiation 2013;85:55-66.
61. Wigle JT, Eisenstat DD. Homeobox genes in vertebrate forebrain development and disease. Clin Genet 2008;73:212-226.
62. Peukert D, Weber S, Lumsden A, Scholpp S. Lhx2 and Lhx9 determine neuronal differentiation and compartition in the caudal forebrain by regulating Wnt signaling. PLoS Biol 2011;9:e1001218.
63. Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I et al. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 2009;65:35-43.
64. Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004;91:238-251.
65. Motohashi N. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:571-579.
66. Al-Jaberi N, Lindsay S, Sarma S, Bayatti N, Clowry GJ. The early fetal development of human neocortical GABAergic interneurons. Cereb Cortex 2013.
67. Liu XS, Chopp M, Kassis H, Jia LF, Hozeska-Solgot A, Zhang RL et al. Valproic acid increases white matter repair and neurogenesis after stroke. Neuroscience 2012;220:313-321.
68. Nerini-Molteni S, Mennecozzi M, Fabbri M, Sacco MG, Vojnits K, Compagnoni A et al. MicroRNA profiling as a tool for pathway analysis in a human in vitro model for neural development. Curr Med Chem 2012;19:6214-6223.
69. Yokoi T, Nakajima M. microRNAs as mediators of drug toxicity. Annu Rev Pharmacol Toxicol 2013;53:377-400.
70. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008;18:610-621.
71. Rosa A, Brivanlou AH. A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 2011;30:237-248.
72. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004;270:488-498.
73. Deng Z, Du WW, Fang L, Shan SW, Qian J, Lin J et al. The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor. J Biol Chem 2013;288:319-331.
74. Bovolenta P, Liem RK, Mason CA. Development of cerebellar astroglia: transitions in form and cytoskeletal content. Dev Biol 1984;102:248-259.
75. Wagh V, Doss MX, Sabour D, Niemann R, Meganathan K, Jagtap S et al. Fam40b is required for lineage commitment of murine embryonic stem cells. Cell Death Dis 2014;5:e1320.